SEARCH

SEARCH BY CITATION

References

  • Appelbaum, F.R. & Anderson, J. (1998) Allogeneic bone marrow transplantation for myelodysplastic syndrome: outcomes analysis according to IPSS score. Leukemia, 12, S25S29.
  • Aul, C., Gattermann, N., Heyll, A., Germing, U., Derigs, G. & Schneider, W. (1992) Primary myelodysplastic syndromes: analysis of prognostic factors in 235 patients and proposals for an improved scoring system. Leukemia, 6, 5259.
  • Balduini, C.L., Guarnone, R., Pecci, A., Centenara, E., Invernizzi, R. & Ascari, E. (1999) The myelodysplastic syndromes: predictive value of eight prognostic systems in 143 cases from a single institution. Haematologica, 84, 1216.
  • Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A., Gralnick, H.R. & Sultan, C. (1982) Proposals for the classification of the myelodysplastic syndromes. British Journal of Haematology, 51, 189199.
  • Cox, D.R. & Oakes, D. (1984) Analysis of Survival Data. Chapman and Hall, London.
  • Estey, E., Keating, M., Pierce, S. & Beran, M. (1997a) Application of the International Scoring System for myelodysplasia to M. D. Anderson patients. Blood, 90, 28432844.
  • Estey, E., Thall, P., Beran, M., Kantarjian, H., Pierce, S. & Keating, M. (1997b) Effect of diagnosis (refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, or acute myeloid leukemia [AML]) on outcome of AML-type chemotherapy. Blood, 90, 29692977.
  • Greenberg, P., Taylor, K., Larson, R., Koeffler, P., Negrin, R., Saba, H., Ganser, A., Jakubowski, A., Gabrilove, J., Mufti, G., Cruz, J., Hammond, W., Broudy, V., Langley, G.R., Keating, A., Vardiman, J., Lamborn, K. & Brown, S. (1993) Phase III randomized clinical multicenter trial of G-CSF vs. observation for myelodysplastic syndromes (MDS). Blood, 82, 196a.
  • Greenberg, P., Cox, C., LeBeau, M.M., Fenaux, P., Morel, P., Sanz, G., Sanz, M., Vallespi, T., Hamblin, T., Oscier, D., Ohyashiki, K., Toyama, K., Aul, C., Mufti, G. & Bennett, J. (1997a) International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood, 89, 20792088.
  • Greenberg, P., Le Beau, M.M. & Fenaux, P. (1997b) Application of the International Scoring System to M. D. Anderson patients. Blood, 90, 28442845.
  • Jaiyesimi, I.A., Friedline, J.A., Mattson, J.C., Gyorfi, T., Davis, B.H., Balasubramaniam, M., Al Khalili, A., Burdakin, Jr, J., Decker, D., Zakalik, D., Neumann, K. & Wilner, F. (2000) Myelodysplastic syndrome at a large tertiary care community hospital: analysis according to the international prognostic scoring system. Leukemia Research, 24, 417426.
  • Keating, M.J., Smith, T.L., Kantarjian, H., Cork, A., Walters, R., Trujillo, J.M., McCredie, K.B., Gehan, E.A. & Freireich, E.J. (1988) Cytogenetic pattern in acute myelogenous leukemia: a major reproducible determinant of outcome. Leukemia, 2, 403412.
  • Lee, J.J., Kim, H.J., Chung, I.J., Kim, J.S., Sohn, S.K., Kim, B.S., Lee, K.H., Kwak, J.Y., Park, Y.H., Ahn, J.S. & Park, Y.S. (1999) Comparisons of prognostic scoring systems for myelodysplastic syndromes: a Korean multicenter study. Leukemia Research, 23, 425432.
  • Maes, B., Meeus, P., Michaux, L., Bijnens, L., Boogaerts, M., Hagemeijer, A., Wolf-Peeters, C. & Verhoef, G. (1999) Application of the International Prognostic Scoring System for myelodysplastic syndromes. Annals of Oncology, 10, 825829.
  • Morel, P., Hebbar, M., Lai, J.L., Duhamel, A., Preudhomme, C., Wattel, E., Bauters, F. & Fenaux, P. (1993) Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases. Leukemia, 7, 13151323.
  • Mufti, G.J., Stevens, J.R., Oscier, D.G., Hamblin, T.J. & Machin, D. (1985) Myelodysplastic syndromes: a scoring system with prognostic significance. British Journal of Haematology, 59, 425433.
  • Nevill, T.J., Fung, H.C., Shepherd, J.D., Horsman, D.E., Nantel, S.H., Klingemann, H.G., Forrest, D.L., Toze, C.L., Sutherland, H.J., Hogge, D.E., Naiman, S.C., Le, A., Brockington, D.A. & Barnett, M.J. (1998) Cytogenetic abnormalities in primary myelodysplastic syndrome are highly predictive of outcome after allogeneic bone marrow transplantation. Blood, 92, 19101917.
  • Oscier, D.G. (1987) Myelodysplastic syndromes. Baillieres Clinical Haematology, 1, 389426.
  • Sanz, G.F., Sanz, M.A., Vallespi, T., Canizo, M.C., Torrabadella, M., Garcia, S., Irriguible, D. & San Miguel, J.F. (1989) Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: a multivariate analysis of prognostic factors in 370 patients. Blood, 74, 395408.
  • Sole, F., Espinet, B., Sanz, G.F., Cervera, J., Calasanz, M.J., Luno, E., Prieto, F., Granada, I., Hernandez, J.M., Cigudosa, J.C., Diez, J.L., Bureo, E., Marques, M.L., Arranz, E., Rios, R., Martinez Climent, J.A., Vallespi, T., Florensa, L. & Woessner, S. (2000) Incidence, characterization and prognostic significance of chromosomal abnormalities in 640 patients with primary myelodysplastic syndromes. Grupo Cooperativo Espanol de Citogenetica Hematologica. British Journal of Haematology, 108, 346356.
  • Sperr, W.R., Wimazal, F., Kundi, M., Fonatsch, C., Thalhammer-Scherrer, R., Schernthaner, G.H., Schwarzinger, I., Haas, O.A., Geissler, K., Lechner, K. & Valent, P. (2001) Survival analysis and AML development in patients with de novo myelodysplastic syndromes: comparison of six different prognostic scoring systems. Annals of Hematology, 80, 272277.
  • Toyama, K., Ohyashiki, K., Yoshida, Y., Abe, T., Asano, S., Hirai, H., Hirashima, K., Hotta, T., Kuramoto, A., Kuriya, S., Miyazaki, T., Kakishita, E., Mizoguchi, H., Okada, M., Shirakawa, S., Takaku, F., Tomonaga, M., Uchino, H., Yasunaga, K. & Nomura, T. (1993) Clinical implications of chromosomal abnormalities in 401 patients with myelodysplastic syndromes: a multicentric study in Japan. Leukemia, 7, 499508.
  • Vallespi, T., Imbert, M., Mecucci, C., Preudhomme, C. & Fenaux, P. (1998) Diagnosis, classification, and cytogenetics of myelodysplastic syndromes. Haematologica, 83, 258275.
  • Yunis, J.J., Lobell, M., Arnesen, M.A., Oken, M.M., Mayer, M.G., Rydell, R.E. & Brunning, R.D. (1988) Refined chromosome study helps define prognostic subgroups in most patients with primary myelodysplastic syndrome and acute myelogenous leukaemia. British Journal of Haematology, 68, 189194.